MatchRX presents: Understanding DSCSA and the Road to 2026 | TWIRx

Pharmacy Podcast Network - Un pódcast de Pharmacy Podcast Network

Podcast artwork

Categorías:

Special Guest: Ilisa B.G. Bernstein, PharmD, JD CEO & Co-founder Johny Kello | MatchRXTopic: DSCSA Compliance, Industry Readiness & the Future of Pharmacy Safety Episode Overview This week on TWIRx, Johny Kello welcomes one of the 50 Most Influential People in Pharmacy, Ilisa B.G. Bernstein, PharmD, JD, to break down the current state of DSCSA compliance as the industry approaches the critical November 2025 enforcement deadline. With decades of leadership in pharmacy practice, regulatory policy, and national advocacy, Dr. Bernstein brings unmatched clarity to what pharmacies must do now — and how the right technology partnerships can keep them operational, efficient, and fully compliant. Together, Johny and Dr. Bernstein discuss why DSCSA readiness remains one of the most pressing challenges for independent and community pharmacies — from data verification and product tracing to avoiding shipment rejections, workflow disruptions, and audit exposure.Johny Kello LinkedIn:https://www.linkedin.com/in/johny-kello/ Ilisa B.G. Bernstein, PharmD, JD LinkedIn:https://www.linkedin.com/in/ilisa-bernstein-b67222174/Learn more: https://www.matchrx.com/Featured guest:Dr. Jordyn Nordé, PharmD, MBA, is a forward-thinking clinical pharmacist and community leader based in St. Louis who combines advanced clinical training with business acumen to drive impact in underserved populations. With experience in ambulatory care and medication management for conditions like hypertension, diabetes and pain, she is also the founder of an initiative bringing minority pharmacy professionals together through mentorship, entrepreneurship and wellness conversations. Her dual credentials enable her to bridge healthcare, professional development and advocacy — positioning her as an emerging influencer in pharmacy practice transformation.LinkedIn: https://www.linkedin.com/in/jordynnorde/

Visit the podcast's native language site